OBJECTIVE: Search and review of available literature were made to define the indications for and timing of liver transplantation for neuroendocrine tumour (NET) liver metastases. METHODS: Electronic bibliographical databases were searched. Prospective and retrospective cohort studies and case-controlled studies were used for qualitative and quantitative synthesis of the systematic review. Reports of patients with liver transplantation alone for NET liver metastases of any origin or combined with resection of extrahepatic tumour deposits were recruited. RESULTS: The number of patients who have undergone liver transplantation for NET liver metastases is 706. The post-transplant 5-year survival rate from the time of diagnosis was approximately 70%. NET patients with metastases confined to the liver and not poorly differentiated are favourable candidates for liver transplantation. Selection of patients based on evolution of tumours over 6 months is not recommended. CONCLUSION: Non-resectable NET liver metastasis resistant to medical treatment and confined to the liver is an accepted indication for liver transplantation.
OBJECTIVE: Search and review of available literature were made to define the indications for and timing of liver transplantation for neuroendocrine tumour (NET) liver metastases. METHODS: Electronic bibliographical databases were searched. Prospective and retrospective cohort studies and case-controlled studies were used for qualitative and quantitative synthesis of the systematic review. Reports of patients with liver transplantation alone for NET liver metastases of any origin or combined with resection of extrahepatic tumour deposits were recruited. RESULTS: The number of patients who have undergone liver transplantation for NET liver metastases is 706. The post-transplant 5-year survival rate from the time of diagnosis was approximately 70%. NET patients with metastases confined to the liver and not poorly differentiated are favourable candidates for liver transplantation. Selection of patients based on evolution of tumours over 6 months is not recommended. CONCLUSION: Non-resectable NET liver metastasis resistant to medical treatment and confined to the liver is an accepted indication for liver transplantation.
Authors: Andrea Frilling; Massimo Malago; Frank Weber; Andreas Paul; Silvio Nadalin; Georgios C Sotiropoulos; Vito Cicinnati; Susanne Beckebaum; Andreas Bockisch; Jan Mueller-Brand; Michael Hofmann; Kurt W Schmid; Guido Gerken; Christoph E Broelsch Journal: Liver Transpl Date: 2006-07 Impact factor: 5.799
Authors: Eliano Bonaccorsi-Riani; Carlos Apestegui; Anne Jouret-Mourin; Christine Sempoux; Pierre Goffette; Olga Ciccarelli; Ivan Borbath; Catherine Hubert; Jean François Gigot; Ziad Hassoun; Jan Lerut Journal: Transpl Int Date: 2010-05-05 Impact factor: 3.782
Authors: Jens Rosenau; Matthias J Bahr; Reinhard von Wasielewski; Michael Mengel; Hartmut H J Schmidt; Björn Nashan; Hauke Lang; Jürgen Klempnauer; Michael P Manns; Klaus H W Boeker Journal: Transplantation Date: 2002-02-15 Impact factor: 4.939
Authors: Patrizia Burra; Giacomo Germani; Renè Adam; Vincent Karam; Alfredo Marzano; Pietro Lampertico; Mauro Salizzoni; Franco Filipponi; Jurgen L Klempnauer; Denis Castaing; Murat Kilic; Luciano De Carlis; Peter Neuhaus; Sezai Yilmaz; Andreas Paul; Antonio D Pinna; Andrew K Burroughs; Francesco P Russo Journal: J Hepatol Date: 2012-10-23 Impact factor: 25.083
Authors: James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans Journal: J Clin Oncol Date: 2008-06-20 Impact factor: 44.544
Authors: Frederike G I van Vilsteren; Edwina S Baskin-Bey; David M Nagorney; Schuyler O Sanderson; Walter K Kremers; Charles B Rosen; Gregory J Gores; Timothy J Hobday Journal: Liver Transpl Date: 2006-03 Impact factor: 5.799
Authors: Y P Le Treut; E Grégoire; J Belghiti; O Boillot; O Soubrane; G Mantion; D Cherqui; D Castaing; P Ruszniewski; P Wolf; F Paye; E Salame; F Muscari; F R Pruvot; J Baulieux Journal: Am J Transplant Date: 2008-04-29 Impact factor: 8.086
Authors: James R Howe; Kenneth Cardona; Douglas L Fraker; Electron Kebebew; Brian R Untch; Yi-Zarn Wang; Calvin H Law; Eric H Liu; Michelle K Kim; Yusuf Menda; Brian G Morse; Emily K Bergsland; Jonathan R Strosberg; Eric K Nakakura; Rodney F Pommier Journal: Pancreas Date: 2017-07 Impact factor: 3.327